Cargando…
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381713/ https://www.ncbi.nlm.nih.gov/pubmed/34426672 http://dx.doi.org/10.1038/s41423-021-00755-z |
| _version_ | 1783741422757740544 |
|---|---|
| author | Hammerschmidt, Swantje I. Bosnjak, Berislav Bernhardt, Günter Friedrichsen, Michaela Ravens, Inga Dopfer-Jablonka, Alexandra Hoffmann, Markus Pöhlmann, Stefan Behrens, Georg M. N. Förster, Reinhold |
| author_facet | Hammerschmidt, Swantje I. Bosnjak, Berislav Bernhardt, Günter Friedrichsen, Michaela Ravens, Inga Dopfer-Jablonka, Alexandra Hoffmann, Markus Pöhlmann, Stefan Behrens, Georg M. N. Förster, Reinhold |
| author_sort | Hammerschmidt, Swantje I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8381713 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83817132021-08-23 Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination Hammerschmidt, Swantje I. Bosnjak, Berislav Bernhardt, Günter Friedrichsen, Michaela Ravens, Inga Dopfer-Jablonka, Alexandra Hoffmann, Markus Pöhlmann, Stefan Behrens, Georg M. N. Förster, Reinhold Cell Mol Immunol Correspondence Nature Publishing Group UK 2021-08-23 2021-10 /pmc/articles/PMC8381713/ /pubmed/34426672 http://dx.doi.org/10.1038/s41423-021-00755-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Hammerschmidt, Swantje I. Bosnjak, Berislav Bernhardt, Günter Friedrichsen, Michaela Ravens, Inga Dopfer-Jablonka, Alexandra Hoffmann, Markus Pöhlmann, Stefan Behrens, Georg M. N. Förster, Reinhold Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination |
| title | Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination |
| title_full | Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination |
| title_fullStr | Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination |
| title_full_unstemmed | Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination |
| title_short | Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination |
| title_sort | neutralization of the sars-cov-2 delta variant after heterologous and homologous bnt162b2 or chadox1 ncov-19 vaccination |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381713/ https://www.ncbi.nlm.nih.gov/pubmed/34426672 http://dx.doi.org/10.1038/s41423-021-00755-z |
| work_keys_str_mv | AT hammerschmidtswantjei neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination AT bosnjakberislav neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination AT bernhardtgunter neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination AT friedrichsenmichaela neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination AT ravensinga neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination AT dopferjablonkaalexandra neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination AT hoffmannmarkus neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination AT pohlmannstefan neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination AT behrensgeorgmn neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination AT forsterreinhold neutralizationofthesarscov2deltavariantafterheterologousandhomologousbnt162b2orchadox1ncov19vaccination |